Interpretation of DAS28 and its components in the assessment of inflammatory and non-inflammatory aspects of rheumatoid arthritis.
作者信息
McWilliams Daniel F, Kiely Patrick D W, Young Adam, Joharatnam Nalinie, Wilson Deborah, Walsh David A
机构信息
1Arthritis Research UK Pain Centre, NIHR Nottingham Biomedical Research Centre & Division of Rheumatology Orthopaedics and Dermatology, University of Nottingham Clinical Sciences Building, City Hospital, Nottingham, NG5 1PB UK.
2Department of Rheumatology, St Georges Healthcare NHS Trust, London, UK.
出版信息
BMC Rheumatol. 2018 Mar 23;2:8. doi: 10.1186/s41927-018-0016-9. eCollection 2018.
Abstract
摘要
相似文献
1
Interpretation of DAS28 and its components in the assessment of inflammatory and non-inflammatory aspects of rheumatoid arthritis.
BMC Rheumatol. 2018 Mar 23;2:8. doi: 10.1186/s41927-018-0016-9. eCollection 2018.
2
A cross-sectional study of pain sensitivity, disease-activity assessment, mental health, and fibromyalgia status in rheumatoid arthritis.
Arthritis Res Ther. 2015 Jan 20;17(1):11. doi: 10.1186/s13075-015-0525-5.
4
Comparison of Disease Activity Score in 28 joints with ESR (DAS28), Clinical Disease Activity Index (CDAI), Health Assessment Questionnaire Disability Index (HAQ-DI) & Routine Assessment of Patient Index Data with 3 measures (RAPID3) for assessing disease activity in patients with rheumatoid arthritis at initial presentation.
Indian J Med Res. 2017 Nov;146(Supplement):S57-S62. doi: 10.4103/ijmr.IJMR_701_15.
5
The subjective components of the Disease Activity Score 28-joints (DAS28) in rheumatoid arthritis patients and coexisting fibromyalgia.
Rheumatol Int. 2018 Oct;38(10):1911-1918. doi: 10.1007/s00296-018-4096-z. Epub 2018 Jun 28.
6
Association of anti-carbamylated protein antibodies with long-term disability and increased disease activity in patients with early inflammatory arthritis: results from the Norfolk Arthritis Register.
Lancet. 2015 Feb 26;385 Suppl 1:S44. doi: 10.1016/S0140-6736(15)60359-2.
7
Comparison of the DAS28-CRP and DAS28-ESR in patients with rheumatoid arthritis.
Int J Rheum Dis. 2015 Jul;18(6):640-5. doi: 10.1111/1756-185X.12695. Epub 2015 May 27.
8
Contribution of the subjective components of the disease activity score to the response to biologic treatment in rheumatoid arthritis.
Arthritis Care Res (Hoboken). 2015 Jul;67(7):923-8. doi: 10.1002/acr.22532.
9
Doppler ultrasound impacts response to intravenous tocilizumab in rheumatoid arthritis patients.
Clin Rheumatol. 2021 Dec;40(12):5055-5065. doi: 10.1007/s10067-021-05857-7. Epub 2021 Jul 16.
10
Contribution of subjective Disease Activity Score 28 (DAS28) components to the response to treatment of rheumatoid arthritis.
Clin Rheumatol. 2017 Jun;36(6):1221-1227. doi: 10.1007/s10067-017-3628-3. Epub 2017 Apr 27.
引用本文的文献
1
Validity and contributions to pain from the central aspects of pain questionnaire in rheumatoid arthritis.
Pain Rep. 2025 Jun 20;10(4):e1295. doi: 10.1097/PR9.0000000000001295. eCollection 2025 Aug.
2
The Erythrocyte Sedimentation Rate (ESR) in Veterinary Medicine: A Focused Review in Dogs and Cats.
Animals (Basel). 2025 Jan 16;15(2):246. doi: 10.3390/ani15020246.
3
Multiscale, mechanistic model of Rheumatoid Arthritis to enable decision making in late stage drug development.
NPJ Syst Biol Appl. 2024 Nov 4;10(1):126. doi: 10.1038/s41540-024-00454-1.
4
Exploration of Risk Factors for Cardiovascular Disease in Patients with Rheumatoid Arthritis: A Retrospective Study.
Inflammation. 2024 Oct 16. doi: 10.1007/s10753-024-02157-5.
5
Contribution of inflammation markers and quantitative sensory testing (QST) indices of central sensitisation to rheumatoid arthritis pain.
Arthritis Res Ther. 2024 Oct 8;26(1):175. doi: 10.1186/s13075-024-03407-5.
6
Bone-protective effects of neutralizing angiopoietin-like protein 4 monoclonal antibody in rheumatoid arthritis.
Mol Ther. 2024 Dec 4;32(12):4497-4513. doi: 10.1016/j.ymthe.2024.09.031. Epub 2024 Oct 4.
7
Further evaluation of inflammatory and non-inflammatory aspects of pain in rheumatoid arthritis patients.
Rheumatol Adv Pract. 2023 Sep 20;7(3):rkad076. doi: 10.1093/rap/rkad076. eCollection 2023.
8
An engineered glove to follow finger function in rheumatoid arthritis: an observational prospective study.
Rheumatol Int. 2024 Feb;44(2):307-318. doi: 10.1007/s00296-023-05444-w. Epub 2023 Sep 13.
9
Joint tenderness at 3 months follow-up better predicts long-term pain than baseline characteristics in early rheumatoid arthritis patients.
Rheumatology (Oxford). 2024 Mar 1;63(3):734-741. doi: 10.1093/rheumatology/kead278.
10
Using the derived 28-joint disease activity score patient-reported components (DAS28-P) index as a discriminatory measure of response to disease-modifying anti-rheumatic drug therapy in early rheumatoid arthritis.
BMC Rheumatol. 2022 Nov 15;6(1):67. doi: 10.1186/s41927-022-00299-3.
本文引用的文献
1
Factors predicting pain and early discontinuation of tumour necrosis factor-α-inhibitors in people with rheumatoid arthritis: results from the British society for rheumatology biologics register.
BMC Musculoskelet Disord. 2016 Aug 12;17:337. doi: 10.1186/s12891-016-1192-7.
2
Association between rheumatoid arthritis disease activity, progression of functional limitation and long-term risk of orthopaedic surgery: combined analysis of two prospective cohorts supports EULAR treat to target DAS thresholds.
Ann Rheum Dis. 2016 Dec;75(12):2080-2086. doi: 10.1136/annrheumdis-2015-208669. Epub 2016 Mar 15.
3
Examining Changes in Central and Peripheral Pain as Mediates of Fatigue Improvement: Results From the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis.
Arthritis Care Res (Hoboken). 2016 Jul;68(7):922-6. doi: 10.1002/acr.22803.
4
Determining Pathways to Improvements in Fatigue in Rheumatoid Arthritis: Results From the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis.
Arthritis Rheumatol. 2015 Sep;67(9):2303-10. doi: 10.1002/art.39238.
5
The Effect of Disease Severity and Comorbidity on Length of Stay for Orthopedic Surgery in Rheumatoid Arthritis: Results from 2 UK Inception Cohorts, 1986-2012.
J Rheumatol. 2015 May;42(5):778-85. doi: 10.3899/jrheum.141049. Epub 2015 Apr 1.
6
A cross-sectional study of pain sensitivity, disease-activity assessment, mental health, and fibromyalgia status in rheumatoid arthritis.
Arthritis Res Ther. 2015 Jan 20;17(1):11. doi: 10.1186/s13075-015-0525-5.
7
Contribution of the subjective components of the disease activity score to the response to biologic treatment in rheumatoid arthritis.
Arthritis Care Res (Hoboken). 2015 Jul;67(7):923-8. doi: 10.1002/acr.22532.
8
Health Assessment Questionnaire disability progression in early rheumatoid arthritis: systematic review and analysis of two inception cohorts.
Semin Arthritis Rheum. 2014 Oct;44(2):131-44. doi: 10.1016/j.semarthrit.2014.05.003. Epub 2014 May 9.
9
Mechanisms, impact and management of pain in rheumatoid arthritis.
Nat Rev Rheumatol. 2014 Oct;10(10):581-92. doi: 10.1038/nrrheum.2014.64. Epub 2014 May 27.
10
Is swollen to tender joint count ratio a new and useful clinical marker for biologic drug response in rheumatoid arthritis? Results from a Swedish cohort.
Arthritis Care Res (Hoboken). 2014 Feb;66(2):173-9. doi: 10.1002/acr.22107.
Zotero 插件